University Hospital Galway — Clinical Trial Site

77 Registered trials

30 Currently recruiting

Organisation

University Hospital Galway

Location

Galway, Ireland

Identifier

ORG-100028882

Address

Newcastle Road, Ireland

Departments

372001: Department of Haematology
3901:Oncology
4403: Cardiology
4803: Pulmonology
Advanced Therapies and Cancer
Anaesthesia and Intensive care medicine
Clinical Biochemistry
Clinical Trials Unit
D10-516 : Nephrology
Department of Medical Oncology
Department of Medicine, Clinical Science Institute
Department of Oncology
Department of Radiation Oncology
Dept of Respiratory Medicine
Emergency Medicine
Endocrinology/ Pharmacology & Therapeutics
Gastroenterology
Haematologist
Haematology
Haematology Department
Haematology Oncology
Hematology
HRB Clinical Research Facility
HRB Clinical Research Facility NUI Galway
HRB-Clinical Research Facility
Infectious Disease
Infectious Diseases
Mecical Oncology
Medical oncology
N/A
Nephrology
Oncology
Oncology Department
Oncology Clinical Trials Unit
Radiation Oncology
Radiation Oncology Department
Radiotherapy
Respiratory Medicine
Rheumatology
University Hospital Dennedy
University Hospital Galway

Clinical trials at this site (77)

Search interface

Clinical trial of MK-2870 in combination with pembrolizumab in people who have had surgery to treat triple negative breast cancer Recruiting

2023-504962-52-00 Triple negative breast cancer. 5 2024-07-10
A study to discover if ZED1227 can improve continued celiac disease symptoms despite a gluten-free diet Recruiting

2023-506150-21-00 Celiac Disease 4 2024-05-29
RADAR: A randomised phase III trial with a PET response adapted design comparing ABVD +/- ISRT with A2VD +/- ISRT in patients with previousl… Recruiting

2022-500031-37-00 stage IA/IIA Hodgkin lymphoma 5 2024-04-08
An Adjuvant Endocrine-based Therapy Study of Camizestrant (AZD9833) in ER+/HER2- Early Breast Cancer (CAMBRIA-2) Recruiting

2023-504031-41-00 ER+/HER2- Early Breast Cancer 5 2024-03-25
Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone versus Lenalidomide Alone in Participants With Newly Dia… Recruiting

2023-510384-36-00 Newly Diagnosed Multiple Myeloma 5 2022-09-13
Study of Neoadjuvant and Adjuvant Treatment in Patients with Resectable Non-small Cell Lung Cancer Recruiting

2023-508852-21-00 Resectable, Early-stage (II to IIIB) Non-small Cell Lun 4 2022-06-10
A randomised, controlled, parallel group, open-label trial evaluating the impact of treatment with the GLP-1 analogue semaglutide on weight … Recruiting

2024-513168-24-00 HIV & Obesity 4 2022-06-01
A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia Recruiting

2022-501050-11-01 Acute Lymphoblastic Leukaemia 10 2020-07-13
Study to assess whether Verekitug can improve the control of Chronic Obstructive Pulmonary Disease (COPD) Ended

2025-520488-42-00 Moderate-to-Severe Chronic Obstructive Pulmonary Diseas 4 2025-09-17
Semaglutide for people with obesity and resistant hypertension (SUPPORT): a pilot, randomized, parallel-group, integrated, multicentre clini… Ended

2024-513958-29-00 Cardiovascular disorders: Hypertension and Obesity 5 2025-04-24
CompARE: Phase III randomised controlled trial Comparing Alternative Regimens for escalating treatment of intermediate and high-risk orophar… Ended

2024-516108-41-00 Oropharyngeal cancer 5 2024-12-09
HARMONi-3 Ended

2024-513087-26-00 Metastatic Non-small Cell Lung Cancer 5 2024-09-10
Vaccination to prevent Mpox Infection (MPOX-VAX Study) Ended

2023-507881-19-00 Mpox infection 6 2024-06-29
A study to test the effect of BI 456906 on cardiovascular safety in people with overweight or obesity Ended

2022-502442-27-00 Obesity 5 2024-01-08
Hidradenitis Suppurativa: Evaluation of Upadacitinib in Adult and Adolescent Subjects Ended

2023-503661-28-00 Hidradenitis Suppurativa 5 2023-10-26
A trial to see if the combination of fianlimab with cemiplimab works better than pembrolizumab for preventing or delaying melanoma from com… Ended

2022-501576-25-00 Melanoma 5 2023-07-07
A study to test trimodulin in adult hospitalized patients with severe pneumonia Ended

2022-501352-28-00 Severe community-acquired pneumonia (sCAP) 5 2023-06-07
Clinical Study of Fianlimab in Combination With Cemiplimab versus Pembrolizumab in Adolescent and Adult Patients With Previously Untreated U… Ended

2023-505772-30-00 Melanoma 5 2022-11-09
A trial to determine the safety and effectiveness of CC-92480 in combination with bortezomib and dexamethasone as compared to pomalidomide i… Ended

2023-509859-13-00 Relapsed or Refractory Multiple Myeloma (RRMM) 5 2022-11-09
A Phase 3 study of Tafasitamab plus Lenalidomide in patients with Relapsed or Refractory Diffuse Large B-Cell Lymphoma. Ended

2023-505579-53-00 Diffuse large B-cell lymphoma (DLBCL) 5 2022-10-25
A study to learn more about how well elinzanetant works and how safe it is compared to placebo for the treatment of hot flashes caused by an… Ended

2023-508265-33-00 Vasomotor symptoms caused by adjuvant endocrine therapy 5 2022-10-13
Coronary Computed Tomography Study to Assess the Effect of Inclisiran in Addition to Maximally Tolerated Statin Therapy on Atherosclerotic P… Ended

2024-511126-31-00 Non-obstructive Coronary Artery Disease 5 2022-08-16
A clinical study that compares a treatment with Iberdomide, Daratumumab and Dexamethasone against a treatment with Daratumumab, Bortezomib, … Ended

2024-510800-35-00 Relapsed or Refractory Multiple Myeloma (RRMM) 5 2022-06-17
Isa-RVD Study: Phase II, Multi-centre, Single-Arm, Open-Label Study to evaluate the efficacy and safety of the combination regimen Isatuxima… Ended

2024-512749-18-00 Newly diagnosed Multiple Myeloma 4 2022-03-03